Boston Scientific Offers World Class Endoscopy Training at its Paris Institute for Advancing Science

PR56764

PARIS, May 15 / PRN=KYODO JBN / --

    - Boston Scientific Reinforces Its Commitment to Global Education and

Innovation

    Boston Scientific Corporation (NYSE:BSX) celebrated the opening of a new

facility dedicated to endoscopy training within its Institute for Advancing

Science in Paris. The ceremony included major representatives of the endoscopy

medical community in Europe. Endoscopy professional training and education is

now part of the multi-disciplinary programs available for European physicians

within the Paris Institute.

    The Institute is fully equipped with state-of-the-art technology to support

integrated hands-on and didactic medical training in endoscopy. It has a broad

range of endoscopes, bronchoscopes, advanced visualization systems and numerous

biological and non-biological models to recreate and simulate adapted clinical

conditions for training and education. Physicians will have access to a

complete endoscopy lab fully equipped with fluoroscopy capabilities and

simultaneous translation facilities. Boston Scientific offers a broad

curriculum of training courses from basic to advanced levels in a range of

specialties and techniques including Endoscopic Retrograde

Cholangiopancreatography (ERCP), Endoscopic Ultrasound (EUS), cholangioscopy

and Bronchial Thermoplasty (BT). The Institute in Paris reinforces the

commitment that Boston Scientific has to innovation and education by offering

world class training facilities designed to meet the educational needs of

endoscopists, endosonographers and pulmonologists.

    Over the last year, Boston Scientific trained more than 25,000 health care

providers worldwide through local and regional programs, seminars,

preceptorships and proctorships. In Europe alone, more than 2,500 nurses and

technicians participated in more than 300 training sessions in more than 12

countries as a part of the Boston Scientific Professional Development Program.

The company also unveiled several new centers of excellence. Last April, Boston

Scientific hosted physicians and fellows at its third Center of Excellence

Workshop at the National University Hospital in Singapore. Earlier this year,

the company launched the Endoscopy Institute in Shanghai, China, which provides

basic through advanced ERCP courses and fellowship training as well as a "train

the trainer" program. In March 2014, seven experts in ERCP participated in the

Institute's first faculty meeting and the first course took place in May. Most

recently, Boston Scientific opened a training center at its Endoscopy

headquarters in Marlborough, Massachusetts, including state-of-the-art

equipment to facilitate education and collaboration with health care providers.

In 2012, Boston Scientific became the first industry partner to commit to the

American Society for Gastrointestinal Endoscopy's (ASGE) capital campaign at

the Cornerstone Level for its global Institute for Training and Technology.

    "The development of endoscopy training demonstrates Boston Scientific's

continued commitment to providing industry-leading training and education in

partnership with physicians and societies to further the practice of

endoscopy," said Paraic Curtis, vice president of Endoscopy Europe Boston

Scientific. "Hands-on training and peer-to-peer education are essential to

maintaining good clinical practice and improving the quality of patient care.

We hope that endoscopy training at the Institute for Advancing Science will

become an integral part of the training continuum of endoscopists and

pulmonologists across Europe."

    To learn more about gastrointestinal products and procedures, please visit

http://www.bostonscientific.com/endo-resources.

    About Boston Scientific

    Boston Scientific transforms lives through innovative medical solutions

that improve the health of patients around the world. As a global medical

technology leader for more than 30 years, we advance science for life by

providing a broad range of high performance solutions that address unmet

patient needs and reduce the cost of healthcare. For more information, visit

http://www.bostonscientific.com and connect on Twitter

[http://twitter.com/bostonsci ] and Facebook

[http://www.facebook.com/bostonscientific ].

    Cautionary Statement Regarding Forward-Looking Statements

    This press release contains forward-looking statements within the meaning

of Section 27A of the Securities Act of 1933 and Section 21E of the Securities

Exchange Act of 1934. Forward-looking statements may be identified by words

like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend"

and similar words. These forward-looking statements are based on our beliefs,

assumptions and estimates using information available to us at the time and are

not intended to be guarantees of future events or performance. These

forward-looking statements include, among other things, statements regarding

our business plans, professional education and training, product performance

and competitive offerings. If our underlying assumptions turn out to be

incorrect, or if certain risks or uncertainties materialize, actual results

could vary materially from the expectations and projections expressed or

implied by our forward-looking statements. These factors, in some cases, have

affected and in the future (together with other factors) could affect our

ability to implement our business strategy and may cause actual results to

differ materially from those contemplated by the statements expressed in this

press release. As a result, readers are cautioned not to place undue reliance

on any of our forward-looking statements.

    Factors that may cause such differences include, among other things: future

economic, competitive, reimbursement and regulatory conditions; new product

introductions; demographic trends; intellectual property; litigation; financial

market conditions; and, future business decisions made by us and our

competitors. All of these factors are difficult or impossible to predict

accurately and many of them are beyond our control. For a further list and

description of these and other important risks and uncertainties that may

affect our future operations, see Part I, Item 1A - Risk Factors in our most

recent Annual Report on Form 10-K filed with the Securities and Exchange

Commission, which we may update in Part II, Item 1A - Risk Factors in Quarterly

Reports on Form 10-Q we have filed or will file hereafter. We disclaim any

intention or obligation to publicly update or revise any forward-looking

statements to reflect any change in our expectations or in events, conditions,

or circumstances on which those expectations may be based, or that may affect

the likelihood that actual results will differ from those contained in the

forward-looking statements. This cautionary statement is applicable to all

forward-looking statements contained in this document.

    Source: Boston Scientific